Angiotech announces sale of Interventional Products Business to Argon Medical Devices, Inc. (via PR Newswire)VANCOUVER, March 25, 2013 /PRNewswire/ – Angiotech Pharmaceuticals, Inc. (“Angiotech”) announced today that it had entered into a definitive agreement to sell certain of its subsidiaries, comprising Angiotech’s Interventional Products Business, to Argon Medical Devices, Inc. (“Argon”), a portfolio…
